-
Publication Venue For
-
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA..
24:1430-1440.
2022
-
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker..
24:1119-1126.
2022
-
Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke..
24:1058-1064.
2022
-
CABANA: underpowered and with detrimental protocol changes: is 'ablation salvation'?-Reply by the authors of the CABANA trial..
24:3.
2022
-
Long-term oral anticoagulant after catheter ablation for atrial fibrillation..
23:1157-1165.
2021
-
Treatment of atrial fibrillation: is it as easy as A-B-C?.
23:161-162.
2021
-
Predictors of recurrence of atrial fibrillation within the first 3 months after ablation..
22:1337-1344.
2020
-
Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5..
22:1026-1035.
2020
-
'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS)..
22:831-832.
2020
-
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary..
22:450-495.
2020
-
Systematic collection of patient-reported outcomes in atrial fibrillation: feasibility and initial results of the Utah mEVAL AF programme..
22:368-374.
2020
-
Death with an implantable cardioverter-defibrillator: a MADIT-II substudy..
21:1843-1850.
2019
-
Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing..
21:1686-1693.
2019
-
Machine learning in 'big data': handle with care..
21:1284-1285.
2019
-
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias..
21:1143-1144.
2019
-
Protamine reversal of heparin: a fishy practice?.
21:840-841.
2019
-
Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices..
21:404-413.
2019
-
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)..
21:7-8.
2019
-
Obstructive sleep apnea is associated with increased rotor burden in patients undergoing focal impulse and rotor modification guided atrial fibrillation ablation..
20:f337-f342.
2018
-
Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis..
20:1621-1629.
2018
-
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)..
20:731-732an.
2018
-
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)..
19:1757-1758.
2017
-
Blunted cyclic variation of heart rate predicts mortality risk in post-myocardial infarction, end-stage renal disease, and chronic heart failure patients..
19:1392-1400.
2017
-
Ranolazine reduces atrial fibrillatory wave frequency..
19:1096-1100.
2017
-
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation..
19:132-138.
2017
-
Challenges in atrial fibrillation beyond stroke prevention: keeping patients out of the hospital..
18:1117-1118.
2016
-
Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF..
18:1135-1142.
2016
-
Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly..
18:794-798.
2016
-
Familial clustering and subsequent incidence of atrial fibrillation among first-degree relatives in Denmark..
18:658-664.
2016
-
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing..
18:159-183.
2016
-
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference..
18:37-50.
2016
-
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)..
17:1197-1214.
2015
-
Antitachycardia pacing for termination of ventricular tachyarrhythmias: should we use it?.
17:1005-1006.
2015
-
Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study..
17:1085-1091.
2015
-
Clinical outcome as a function of the PR-interval-there is virtue in moderation: data from the Duke Databank for cardiovascular disease..
17:978-985.
2015
-
Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme..
17:787-793.
2015
-
B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies..
16:1426-1433.
2014
-
Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease..
16:1284-1290.
2014
-
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry..
16:308-319.
2014
-
Validation of non-contact and point-to-point mapping in a single electroanatomic map..
16:371.
2014
-
Risk assessment in atrial fibrillation: not all factors are created equal..
16:156-158.
2014
-
Evaluating strict and conventional left bundle branch block criteria using electrocardiographic simulations..
15:1816-1821.
2013
-
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference..
15:1540-1556.
2013
-
The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients..
15:992-1001.
2013
-
Multi-scale heart rate dynamics detected by phase-rectified signal averaging predicts mortality after acute myocardial infarction..
15:437-443.
2013
-
Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis..
14:1602-1607.
2012
-
Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy..
13:1717-1722.
2011
-
Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?.
13:295-296.
2011
-
Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials..
13:193-204.
2011
-
Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial..
12:1112-1118.
2010
-
Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias..
10:988-997.
2008
-
Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registries.
2020